How life sciences companies can use LinkedIn as a strategic marketing channel

Key takeaways

• LinkedIn gathers biotech executives, clinical research leaders, procurement teams and KOLs in one professional network with precise targeting.
• Thought leadership on LinkedIn can outweigh brand size, since 53% of B2B decision-makers say brand recognition counts for less when thought leadership is strong.
• Educational posts, research highlights, behind-the-science stories, gated assets and video or carousels perform best.
• Paid formats such as Sponsored Content, Lead Gen Forms and retargeting reach exact roles, but costs run higher than other platforms.
• MLR review, a clear line between science and promotion and trained employee advocates keep activity compliant.

Life sciences companies can use LinkedIn as a strategic marketing channel because it puts biotech VPs, clinical research directors, procurement leads and leading physicians and researchers in one professional space. Reaching those people elsewhere is hard and expensive. This Emulent guide covers who to target, what content works, how to use LinkedIn ads, how to stay compliant and how to measure results.

Why does LinkedIn work differently for life sciences than other industries?

LinkedIn works differently because it centers on professional identity, which matches how people in life sciences evaluate partners and vendors. Most social platforms focus on entertainment and personal connections, while LinkedIn users come to learn and do business.

The platform lets you target by job title, function, company, industry, seniority, skills and degrees, so you can reach the exact professionals who influence a purchase. LinkedIn now has more than 1 billion members across 200+ countries and regions, including many senior decision-makers in pharma, biotech and medical devices.

Expertise also carries unusual weight on the platform. The 2025 Edelman-LinkedIn B2B Thought Leadership Impact Report found that 53% of B2B decision-makers say brand recognition counts for less when a company’s thought leadership is strong. That gives smaller life sciences firms a real opening against larger competitors.

Many companies treat LinkedIn like a press release board, posting news and waiting. The ones that build pipeline on the platform share expertise and engage in conversation.

Who are you actually trying to reach on LinkedIn?

You should define your audience before writing a single post, because life sciences spans very different buyers. A CRO’s LinkedIn plan looks nothing like a diagnostics company’s.

• C-suite and VP executives read content on strategy, market trends and organizational growth.
• Healthcare professionals respond to clinical data, treatment updates and education tied to patient outcomes.
• Researchers and scientists want technical depth, instrument comparisons and methodology, not sales language.
• Procurement and regulatory professionals care about compliance, vendor reliability and documentation.
• Business development and partnership leads look for licensing, collaboration and strategic partnership opportunities, and LinkedIn is one of their main research tools.

The more precisely you define each segment, the more your content connects. Generic life sciences posts rarely produce results.

What types of content perform best for life sciences on LinkedIn?

The content that performs best teaches, informs or sparks new thinking about work. For life sciences companies, that means sharing real expertise instead of treating LinkedIn as a company newsletter. Frame every news item or product update around how it affects your audience.

• Educational posts explain a regulatory change, study finding or technical process in plain language.
• Research highlights pull one finding from a study and connect it to a business or clinical implication.
• Behind-the-science content shows the people, process or problem-solving behind a product and humanizes your brand.
• Gated white papers, technical guides, case studies and research reports can be shared through Lead Gen Forms.
• Short explainer videos, lab walkthroughs and slide carousels make complex topics easier to follow and tend to draw more engagement than plain text.

The fastest-growing programs usually let scientists and medical directors post as themselves, because peers trust individual experts more than company pages.

How should life sciences companies use LinkedIn ads?

Life sciences companies should use LinkedIn ads to reach specific roles at scale, while organic content builds authority. Ads cost more per click than many platforms, but the precision often justifies it for high-value B2B deals.

You can target clinical operations managers at mid-size biotechs, regulatory leads at device companies or procurement directors at health systems directly.

• Sponsored Content appears natively in the feed and works for educational content, gated assets and traffic to specific pages.
• Lead Gen Forms attach a pre-filled form to sponsored posts and remove landing page friction for white papers, webinars and consultations.
• Message Ads deliver a personal message to a target’s inbox for high-value segments such as VP-level executives, where the format is available.
• Dynamic Ads personalize messaging using viewer profile information for awareness campaigns.
• Retargeting re-engages people who visited your site, watched a video or opened a Lead Gen Form, and usually converts better because the audience already knows you.

Start with one audience segment and one clear goal, then expand once you know your cost per qualified lead. Send ad traffic to fast, focused landing pages.

Does regulatory risk limit what life sciences companies can say on LinkedIn?

Regulatory risk shapes what you can say, but it does not prevent an active presence. Pharma and device companies face FDA promotion rules, and FDA stepped up enforcement on drug promotion in 2025, so caution is reasonable. The answer is to separate education from promotion.

You can post about disease awareness, scientific research, industry trends, clinical methods and company milestones without making product claims.

• Route LinkedIn posts through medical, legal and regulatory review like any other material, and plan a calendar so review does not slow you down.
• Discuss the science, research or clinical problem your product addresses without specific product claims.
• When referencing clinical data, include appropriate context and link to full publications instead of summarizing results selectively.
• Train scientists and executives who post on what they can and cannot say about products in development or off-label uses.

Regulatory risk is real but manageable. Doing nothing out of excess caution carries its own cost, since competitors are building audiences in the meantime.

How do you measure whether your LinkedIn strategy is working?

You measure LinkedIn by connecting activity to pipeline, not impressions. Native analytics, read correctly, show what builds pipeline and what only generates reach.

• Follower growth by segment shows whether your audience matches the industries, functions and seniority you target.
• Engagement rate by content type, calculated as engagements divided by impressions, shows which formats and topics work.
• Lead Gen Form completion rate shows whether your offer and form length fit the audience.
• Website visits from LinkedIn, tracked with UTM parameters, show which pages LinkedIn traffic reaches and whether it converts.
• Pipeline attribution, built with your sales team and CRM, shows which deals LinkedIn started or influenced.

Review results monthly for tactics and quarterly for strategy.

How do you build a LinkedIn presence that holds up over time?

You build a durable presence through consistency, which is what separates companies with real authority from those that post now and then. Three things keep a program going: a realistic content calendar, a few internal champions who post from their own profiles and a clear tie between LinkedIn activity and business goals.

Plan in quarters rather than single posts, and map content to your pipeline goals, conference calendar and product milestones.

How can the Emulent team help?

Emulent helps life sciences companies research their audiences, plan content, run compliant LinkedIn campaigns and connect results to revenue. If you want LinkedIn to become a real source of pipeline instead of a place to post updates, contact the Emulent team to build a LinkedIn strategy that fits your goals.